Total Payments
$43,517
2024 Payments
$22,914
Companies
15
Transactions
113
Medicare Patients
14,964
Medicare Billing
$10.5M
Payment Breakdown by Category
Other$26,466 (60.8%)
Consulting$12,052 (27.7%)
Food & Beverage$2,749 (6.3%)
Travel$2,180 (5.0%)
Education$69.95 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,578 | 10 | 47.3% |
| Consulting Fee | $12,052 | 4 | 27.7% |
| Honoraria | $5,889 | 6 | 13.5% |
| Food and Beverage | $2,749 | 85 | 6.3% |
| Travel and Lodging | $2,180 | 6 | 5.0% |
| Education | $69.95 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $19,070 | 22 | $0 (2024) |
| Genentech USA, Inc. | $6,768 | 11 | $0 (2024) |
| Alimera Sciences, Inc. | $6,161 | 10 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $3,963 | 33 | $0 (2024) |
| F. Hoffmann-La Roche AG | $2,878 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $2,050 | 1 | $0 (2021) |
| Allergan Inc. | $1,670 | 3 | $0 (2018) |
| EyePoint Pharmaceuticals US, Inc. | $285.00 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $277.85 | 16 | $0 (2024) |
| NotalVision | $98.89 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,914 | 51 | Astellas Pharma US Inc ($18,955) |
| 2023 | $2,043 | 27 | Alimera Sciences, Inc. ($1,420) |
| 2022 | $298.98 | 9 | Apellis Pharmaceuticals, Inc. ($160.54) |
| 2021 | $6,537 | 6 | Alimera Sciences, Inc. ($4,476) |
| 2019 | $76.15 | 1 | Genentech USA, Inc. ($76.15) |
| 2018 | $2,947 | 3 | F. Hoffmann-La Roche AG ($2,878) |
| 2017 | $8,700 | 16 | Genentech USA, Inc. ($6,657) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Ophthalmology | ||||||
| 12/17/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: Ophthalmology | ||||||
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: EYE CARE | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Izervay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Ophthalmology | ||||||
| 10/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/30/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: Ophthalmology | ||||||
| 09/30/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: Ophthalmology | ||||||
| 09/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Ophthalmology | ||||||
| 08/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/06/2024 | Astellas Pharma US Inc | Izervay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Ophthalmology | ||||||
| 08/05/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Ophthalmology | ||||||
| 07/29/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: EYE CARE | ||||||
| 07/11/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Ophthalmology | ||||||
| 07/11/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: Ophthalmology | ||||||
| 07/02/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Ophthalmology | ||||||
| 06/14/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Ophthalmology | ||||||
| 05/31/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Ophthalmology | ||||||
| 05/31/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 4,193 | 29,916 | $13.2M | $3.0M |
| 2022 | 21 | 3,723 | 14,919 | $10.4M | $2.4M |
| 2021 | 20 | 3,485 | 13,950 | $10.8M | $2.7M |
| 2020 | 17 | 3,563 | 12,348 | $9.5M | $2.4M |
Total Patients
14,964
Total Services
71,133
Medicare Billing
$10.5M
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 117 | 1,112 | $2.8M | $770,950 | 27.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 100 | 2,425 | $2.4M | $453,701 | 18.7% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 47 | 15,480 | $1.9M | $450,674 | 23.3% |
| J3490 | Unclassified drugs | Office | 2023 | 46 | 209 | $1.2M | $384,929 | 31.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 645 | 1,551 | $567,666 | $167,707 | 29.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 295 | 1,816 | $951,064 | $166,200 | 17.5% |
| J3590 | Unclassified biologics | Office | 2023 | 44 | 77 | $507,000 | $165,340 | 32.6% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 61 | 650 | $650,000 | $139,671 | 21.5% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 26 | 1,005 | $368,503 | $120,962 | 32.8% |
| 92134 | Imaging of retina | Office | 2023 | 790 | 2,254 | $1.0M | $76,157 | 7.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 335 | 413 | $149,506 | $30,864 | 20.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 736 | 1,593 | $183,195 | $20,354 | 11.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 152 | 152 | $71,440 | $19,289 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 156 | 235 | $60,395 | $15,327 | 25.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 131 | 171 | $44,289 | $13,098 | 29.6% |
| 65800 | Removal of eye fluid | Office | 2023 | 35 | 127 | $64,000 | $12,656 | 19.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 50 | 123 | $80,688 | $8,197 | 10.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 49 | 54 | $20,142 | $6,465 | 32.1% |
| 92250 | Photography of the retina | Office | 2023 | 127 | 155 | $30,070 | $4,871 | 16.2% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 20 | 23 | $28,152 | $4,280 | 15.2% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 166 | 208 | $26,000 | $4,050 | 15.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 32 | 47 | $12,361 | $1,943 | 15.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $5,072 | $1,185 | 23.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 17 | 20 | $3,500 | $573.39 | 16.4% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 126 | 4,149 | $4.1M | $914,404 | 22.0% |
About Dr. Daniel Roth, MD
Dr. Daniel Roth, MD is a Ophthalmology healthcare provider based in New Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538132352.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Roth, MD has received a total of $43,517 in payments from pharmaceutical and medical device companies, with $22,914 received in 2024. These payments were reported across 113 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,578).
As a Medicare-enrolled provider, Roth has provided services to 14,964 Medicare beneficiaries, totaling 71,133 services with total Medicare billing of $10.5M. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location New Brunswick, NJ
- Active Since 02/10/2006
- Last Updated 08/01/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1538132352
Products in Payments
- Izervay (Drug) $18,955
- Non-Covered Product (Drug) $6,637
- ILUVIEN (Drug) $5,896
- Syfovre (Drug) $3,736
- Lucentis (Biological) $2,974
- BEOVU (Drug) $2,050
- EYLEA (Biological) $251.51
- Iluvien (Biological) $245.06
- YUTIQ (Drug) $189.85
- OZURDEX (Drug) $150.09
- EYP-1901 (Drug) $114.45
- EYLEA HD (Biological) $102.61
- ForeseeHome (Device) $98.89
- XIPERE (Drug) $27.14
- Vabysmo (Drug) $20.12
- VABYSMO (Drug) $14.57
- Cimerli (Biological) $14.17
- EYLEA AFLIBERCEPT INJECTION (Biological) $13.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in New Brunswick
Dr. Howard Fine, Md Mhsc, MD MHSC
Ophthalmology — Payments: $959,730
Ophthalmology $959,730
Dr. Jonathan Prenner, Md, MD
Ophthalmology — Payments: $259,427
Ophthalmology $259,427
Dr. Sumit Shah, M.d, M.D
Ophthalmology — Payments: $80,149
Ophthalmology $80,149
Dr. Bruce Keyser, Md, MD
Ophthalmology — Payments: $8,241
Ophthalmology $8,241
Dr. Dimosthenis Mantopoulos, M.d, M.D
Ophthalmology — Payments: $5,665
Ophthalmology $5,665
Dr. Elizabeth Tegins, Md, MD
Ophthalmology — Payments: $2,545
Ophthalmology $2,545